Succession sale

Biotechnologie GmbH Life Sciences ca. 6 Mio. EUR Umsatz NRW

State: Nordrhein-Westfalen
Buyer interest
40/100
Days since opening
Share capital
Industry
Healthcare & medical

AI-generated dossier

What does the company do / sell to whom in which region? According to the sales offer on nexxt-change, the company is described as an established biotechnology / life sciences GmbH with a global distribution network in approximately 65 countries. Specific products, product lines, or end customers are not mentioned in the available listing; the offer suggests sales through dealers/distributors and international markets. No detailed product pages or a standalone company website were found in the fetched data. Size + visible indicators The listing mentions about 35 employees and a revenue of around 5–6 million EUR; a purchase price of 5,000,000 € is indicated in the advertisement. The presence of the offer is documented on the nexxt-change platform. There are no entries in the commercial register and no annual financial statements published in the Bundesanzeiger. Wayback records show a fi

Register for free to read the complete dossier.

Synthesised from Handelsregister, Bundesanzeiger, §9 notice, web presence and news.

Continue reading — free

AI · New

Personal Deal Playbook

An AI-generated action plan for this specific case + your buyer profile — fit, structure, administrator outreach, questions, risks.

With a free account and a buyer profile you get a personalised action plan for EVERY case on this platform.

Preview (locked)

  • Fit•• / 100
  • Estimated asset value•• EUR
  • Budget alignment•••
  • First-outreach draft•• sentences
  • 3 key questions for first call•••
  • 3 case-specific risks•••

Key deadlines

Claim deadline
§174 InsO — deadline for creditors to lodge claims with the administrator.
Report meeting
§29 InsO — first creditors' meeting, administrator presents restructuring vs. liquidation plan.
Verification meeting
§29 InsO — verification of the lodged claims.

Web presence

Buyer interest score

40/ 100

Proprietary composite: 0-100 based on web resolution, dossier depth, news, procedure type and bid timing.

Web resolution
20/20
Dossier depth
20/20
News activity
0/20
Debtor-led procedure
0/20
Bid-phase timing
0/20

Does this company match your search?

Score the fit against your buyer profile — sector, region, size, deal structure.

45-95 % match probability — full analysis with a free buyer profile.

Score the fit against your buyer profile — sector, region, size, deal structure.

Create buyer profile — free

Risk signals

  • No entry in the commercial register found in the fetched data
  • No annual financial statements published in the Bundesanzeiger found
  • No insolvency announcement or court records in the fetched data
  • Company presence primarily through sales offer on nexxt-change
  • No Trustpilot reviews or other customer feedback in the data
  • Wayback First Capture 2025 (limited previous web history in the fetched records)

Positive signals

  • Sales offer mentions approximately 35 employees and ~5–6 million € in revenue
  • Listing claims a global distribution network in 65 countries
  • WHOIS entry with registration date of 2005-12-08 (long-standing domain registration)
  • Offer is listed on the nexxt-change platform (public sales advertisement)

Network & related entities

Shareholders, directors and related companies derived from commercial register data.

Network analysis for boutique customers

Ownership structures, shareholder lists and related entities are part of the Boutique plan.

Similar proceedings

What now? Buyer's guide

How does an insolvency asset deal work? What deadlines matter? When is the best moment to talk to the administrator?

Related knowledge

External sourcesExtra verification sources — deep-linked to the right view when possible.